Diagnosing and managing cystic fibrosis in the developing world
Sushil K Kabra1, M Kabra, S Shastri
1Department of Pediatrics, New Delhi 110-029, India. skkabra@hotmail.com
Paediatric Respiratory Reviews
|June 27, 2006
Summary
Cystic fibrosis (CF) is a global disease. Resource-limited settings can improve CF care through pediatrician education, indigenous diagnostic tools, and tailored treatments, enhancing patient survival and quality of life.
Area of Science:
- Medical Science
- Pediatrics
- Genetics
Background:
- Cystic fibrosis (CF) is increasingly recognized as a pan-ethnic disease, affecting diverse populations globally.
- Developing countries face significant challenges in diagnosing and managing CF due to limited resources, lack of awareness, and inadequate infrastructure.
Purpose of the Study:
- To explore strategies for establishing and improving Cystic fibrosis (CF) care services in resource-limited settings.
- To identify key challenges and propose feasible solutions for CF diagnosis and management in developing countries.
Main Methods:
- Development of an inexpensive, indigenous method for sweat chloride estimation using pilocarpine iontophoresis and titration.
- Adaptation of available resources for comprehensive CF patient care, including training single healthcare professionals for multi-disciplinary roles.
- Utilization of locally available medications as alternatives to specialized CF drugs.
Main Results:
- An indigenous sweat chloride estimation method offers a cost-effective alternative to commercial equipment.
- Training a single nurse to provide comprehensive CF care is a feasible approach in resource-limited environments.
- Local medications, such as hypertonic saline and enteric-coated enzymes, can effectively manage CF symptoms.
Conclusions:
- Early diagnosis through pediatrician education and indigenous technology is crucial for improving outcomes in Cystic fibrosis (CF).
- Aggressive physiotherapy, nutritional management, and judicious antibiotic use are vital for enhancing the quality of life and survival rates in CF patients.
- Successful implementation of CF services in resource-limited settings is achievable through innovative and adapted strategies.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation